Navigation Links
New findings by St. Michael's researchers about the way cells work
Date:1/10/2012

Marsden has found that too much communication between SDF-1 and CXCR4 molecules can also impact the development of HUS in animals and humans. His team made two important discoveries, published in The Journal of Clinical Investigation:
  • injecting the drug plerixafor/AMD3100 (sold under the brand name Mozobil) into mice exposed to the E. coli toxin changed their survival rate and helped improve the HUS, suggesting future therapy options for humans. The drug blocks SDF-1 action on cells that express CXCR4. The drug is used to mobilize precursor stem cells from the bone marrow in some bone marrow transplant recipients during the treatment of non-Hodgkin lymphoma and multiple myeloma.
  • blood tests taken from children with E. coli showed that those who went on to develop HUS had higher levels of the protein SDF-1as much as four times higher than other children with E. coli who did not go on to develop HUS. This suggests that a blood test could be used to predict who is most likely to develop the potentially fatal HUS, meaning they could be monitored more closely.

Dr. Marsden, who is a nephrologist, said a safe water supply and clean food supply chain is the most important step in preventing HUS caused by E. coli.

"If we can measure SDF-1 levels in real time during an E. coli outbreak and confirm these findings, then we have a strong case for a trial of plerixafor/AMD3100 in patients with toxin-producing E. coli to see if it prevents or improves cases of HUS," he said.


'/>"/>

Contact: Leslie Shepherd
shepherdl@smh.ca
416-864-6094
St. Michael's Hospital
Source:Eurekalert

Page: 1 2

Related biology news :

1. September 2007 Sumatran earthquakes research findings
2. Findings uncover new details about mysterious virus
3. Nearly a century later, new findings support Warburg theory of cancer
4. New research findings may enable earlier diagnosis of uterine cancer
5. Therapeutic cloning gets a boost with new research findings
6. International climate change researchers meet, review latest findings
7. Findings show insulin -- not genes -- linked to obesity
8. FANTOM findings boost for biologists
9. New findings in taste and smell
10. SRI International announces findings from new upper atmospheric radar system for scientific research
11. USC researchers present diabetes findings at American Diabetes Association Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market and creator of ... Smart Card Alliance and the EMV Migration Forum.  ... Smart Card Alliance Latin America (SCALA) Chapter provides NXT-ID, ... thought leaders promoting adoption of smart card technology. ...
(Date:8/12/2015)... 2015   MedNet Solutions , an innovative SaaS-based ... clinical research, is proud to announce that ... eClinical technology platform, has led the way to significant ... of 2015.   Q2 2015 and Q1 2015 were, ... contract value sold in the company,s 15 year history.  ...
(Date:8/10/2015)... Germany , August 10, 2015 /PRNewswire/ ... world leader in Eye Tracking Technology for more than ... Eye Tracking Platform for integration into all consumer display ... designs for seamless integration of eye tracking into consumer ... and augmented reality smart glasses. Omnivision,s leading sensor technology ...
Breaking Biology News(10 mins):NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4MedNet Solutions Experiences Explosive Corporate Growth 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3
... have 5.5 times higher levels of cotinine, a byproduct of ... from Warwick Medical School at the the University of Warwick, ... print in Archives of Disease in Childhood. , ... biggest independent effect on cotinine in the urine – quadrupling ...
... the microscopic scaffolding that the cell uses to move ... divide, originated from a tiny structure near the nucleus, ... University Medical Center reveal a surprising new origin for ... Cell, Irina Kaverina, Ph.D., and colleagues report that the ...
... defined based on what they can become: more of themselves, ... genetic techniques have become increasingly powerful, many scientists have sought ... genes they express. , Now, a team of Canadian ... gene called Oct4 considered to be the master regulator of ...
Cached Biology News:Children of smokers have more than 5 times higher levels of a nicotine toxin 2Surprising origin of cell's internal highways 2Surprising origin of cell's internal highways 3Study identifies 5 genetic themes key to keeping stem cells in a primitive, flexible state 2
(Date:8/28/2015)... /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) ... on the development of autologous cell therapies, today ... 30, 2015, corporate highlights, and near-term milestones.  The ... at www.sedar.com ,  www.edgar.com and ... expects to launch its RCS-01 treatment for aging ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... ... opportunity for venture capital funds, investment firms and animal health companies to hear ... have raised $160 million. Several have also received licensing agreements or distribution contracts. ...
(Date:8/27/2015)... - Portage Biotech Inc. ("Portage") (OTC Market: PTGEF, ... Company Limited (Biohaven), announced today that dosing has ... a glutamate modulating agent. Biohaven filed an investigational ... clearance from the U.S. Food and Drug Administration ... 54% equity interest in Biohaven, a private company. ...
(Date:8/27/2015)... BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its ... Biorem,s complete second quarter financial statements and MD&A have been filed ... earnings per shareThree-months ended , Six -months endedJune 30 , June ... , 2014 Revenue , 4,709 , 2,459 ... 1,656 , 56 , 3,188 ...
Breaking Biology Technology:RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4BIOREM Reports $718,000 Net Earnings for the Second Quarter 2BIOREM Reports $718,000 Net Earnings for the Second Quarter 3
... report addresses regulatory oversight for emerging technologyWASHINGTON, March ... synthetic biology may be adequately addressed by the ... laboratories and manufacturing facilities. But further advances in ... challenges for U.S. government oversight, according to a ...
... group of executives who represent an array of energies ranging from solar ... to tread carefully when putting together U.S. energy policy. , ... Houston, ... a group of executives who represent an array of energies ranging from ...
... S.A. and,Solvay Pharmaceuticals Marketing and Licensing AG (subsidiary ... partnership agreement for the,promotion and distribution of Stallergenes ... of Independent States (CIS). , ... and a strong demand on the,part of the ...
Cached Biology Technology:Synthetic Biology: The Next Biotech Revolution Is Brewing 2Synthetic Biology: The Next Biotech Revolution Is Brewing 3Energy Leaders Gather in Houston; Call for Balanced, Careful Approach to Energy Policy 2Energy Leaders Gather in Houston; Call for Balanced, Careful Approach to Energy Policy 3Stallergenes Signs an Exclusive Partnership Agreement With Solvay Pharmaceuticals for the Promotion and Distribution of its Products in Russia and the CIS* 2Stallergenes Signs an Exclusive Partnership Agreement With Solvay Pharmaceuticals for the Promotion and Distribution of its Products in Russia and the CIS* 3
Anti-human L-Ficolin, Clone GN4, Monoclonal Antibody...
B3GALT2 Immunogen: B3GALT2 (NP_003774, 324 a.a. ~ 423 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
... ( Abpromise for all tested applications). ... KLH derived from within residues 500 to the ... acid sequence is proprietary) (Peptide ... Entrez Gene ID: 51043 ...
Rabbit polyclonal to SUR1 ( Abpromise for all tested applications). Antigen: Synthetic peptide Entrez Gene ID: 6833 Swiss Protein ID: Q09428...
Biology Products: